For Institutional Buyers and Accredited Investors Only
Kevin Harrington of Shark Tank
Vivos Therapeutics, Inc. is a medical technology manufacturer focused on the development and commercialization of solutions for patients with sleep disordered breathing (SDB), including obstructive sleep apnea (OSA). Registered with the FDA as a Specification Developer, we develop and market a number of FDA cleared and registered specially-designed, customized and preformed oral appliances.
Our technology represents the first non-surgical, non-invasive and cost-effective solution for the hundreds of millions of people globally who suffer from OSA. The Vivos System is a proprietary therapeutic protocol of functional and oral appliance therapy that we believe is gently remodeling and enhancing the size, shape, and function of the airway by mimicking biological processes.
The Vivos System has been shown to significantly lower Apnea Hypopnea Index (AHI) scores and improve other conditions associated with OSA.
Vivos clinicians can be found in almost every major city in the U.S. and in many countries throughout the world. Our oral appliances have shown to be effective in over 8,000 patients successfully treated worldwide by approximately 1,000 trained dentists.
The Vivos System can reduce or possibly eliminate the need for surgery or lifetime CPAP or mandibular advancement oral therapy.
The Vivos System is affordable and treatment applicable and effective in people of all ages and most major commercial insurance payers reimburse for Vivos System treatment
According to a 2019 publicly available analysis from researchers at the University of California, San Diego, an estimated 81 million adults in the North and South America suffer from moderate to severe OSA. The United States has the highest amount of these patients with approximately 54 million adults affected, according to such analysis.
In line with our growth strategy, our company has established FDA approved and registered manufacturing facilities in the US, Canada and Asia.
Do you know someone who suffers
from obstructive sleep apnea?
Sleep disordered breathing including mild-to-moderate obstructive sleep apnea affects millions of people of all ages. More than 85% of individuals who suffer from OSA remain undiagnosed and those who know they have it must face a lifetime of treatment using CPAP or invasive surgery.
How does Vivos compare with other treatment modalities?
A New Paradigm in Sleep Medicine
Obstructive Sleep Apnea
A Serious Concern for Every Doctor
As a physician, you see patients everyday who are suffering from the affects of Obstructive Sleep Apnea. You have very few treatment options.
What if there was another way?
Sleep Disordered Breathing Comorbidities
Explore the anatomy of sleep disordered breathing including mild-to-moderate obstructive sleep apnea.
Sleep disordered breathing
obstructive sleep apnea may
impact every system
in the body.
Explore the anatomy of sleep disordered breathing including
mild-to-moderate obstructive sleep apnea.
Interrupted sleep may impact every system in the body.
Sillah, Arthur et al. “Obstructive sleep apnea severity and subsequent risk for cancer incidence.” Preventive medicine reports vol. 15 100886. 2 May. 2019, doi:10.1016/j.pmedr.2019.100886
Standard of Care
Existing palliative treatment options are undesirable.
Treatment options to relieve and manage symptoms.
While existing treatment options are effective to relieve the visible symptoms and manage the affects obstructive sleep apnea, they ultimately do not address the underlying condition in 87% of cases.
While these treatments can be effective at managing the symptoms of OSA, they do not correct the underlying problem.
Patient Compliance is Critical for Success
Non-Compliance – The Leading Cause of Poor Treatment Outcomes
”“Despite the efficacy of CPAP in reversing sleep apnea, of those studies using the cut point of at least 4 hours per night to define adherence, 29% to 83% of patients were non-adherent.”ATS Journals – American Thoracic SocietyNovember 30, 2007
Biomimetic Oral Appliance Therapy
A treatment protocol that targets the underlying cause of sleep apnea.
The Vivos System® works to treat the root cause of OSA by non-surgically remodeling and repositioning the hard and soft tissues that comprise the human airway.
The Vivos System® treatment is typically less than $10,000 and is covered by most major health plans.
A potentially serious medical problem with a solution in the dental office.
Hard and soft tissues of the craniofacial complex can be non-surgically remodeled and enhanced using the proprietary Vivos System® devices and clinical protocols.
The following slides exemplify the numerous ways in which the Vivos System® operates to remodel, reposition, and enhance craniofacial tissues.
OSA Resolved Non-Surgically
An Obstructed Airway
Target and treat the underlying condition.
”“In 98% of patients with OSA, the condition is due to abnormal anatomical features of the soft tissues and/or the structures of the maxillomandibular skeleton that cause a disproportionate anatomy of the airway.”Arch Otolaryngol Head Neck Surg.2011; 137(10):990-996
Pneumopedics® – A Therapeutic Breakthrough
The Vivos System® offers new hope to what has otherwise been a bleak prognosis for patients with OSA.
Since 2009, over 12,000 patients around the world have been treated using proprietary Vivos technology.
Some doctors claim it has cured their patients. Over 50 published articles / studies consistently show >50% drop in AHI scores for most patients.
Pneumopedics® is the natural process induced by Vivos biomimetic technology by which the airway tissues are remodeled resulting in enhanced capacity.
The Vivos System® multidisciplinary treatment protocol involves collaboration between physicians, specially-trained dentists who have completed advanced training in craniofacial sleep medicine, and other ancillary healthcare providers.
Dental Success Institute – The Dentalpreneur Podcast
Stem Cells, Sleep, and Your Practice with Dr. Dave Singh, DMD Phd DDSc